A Review on Suggested Mechanisms in Thrombocytopenia and Thrombosis Following ChAdOx۱ nCoV-۱۹ Vaccination
Publish place: Research in Molecular Medicine، Vol: 9، Issue: 4
Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 89
This Paper With 8 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_REMJ-9-4_001
تاریخ نمایه سازی: 20 دی 1402
Abstract:
Background: ChAdOx۱ nCov-۱۹ vaccine is a viral vector-based vaccine with desirable protection (about ۷۰.۴%, two weeks after the second dose). Few reports were released on thrombocytopenia associated with thrombotic events shortly after the ChAdOx۱ nCov-۱۹ vaccination. However, the exact pathophysiologic mechanism of this vaccineinduced thrombotic complication has not yet been elucidated. Vaccine-induced thrombotic thrombocytopenia syndrome (VITTS) is associated with detecting anti-platelet factor ۴ (PF۴) antibodies that are not yet linked to previous exposure to heparin.
Materials and Methods: In the current review, based on relevantly reported cases, possible mechanisms are suggested on the relationship between the anti-platelet factor ۴ (anti-PF۴) antibody assays, previous exposure to heparin, and the involved mechanisms of post-vaccination thrombocytopenia and thrombotic events, which might help the experts for selecting the appropriate therapeutic measures.
Results: Possibly involved mechanisms in VITTS after ChAdOx۱ nCoV-۱۹ vaccination include binding of anti-PF۴ antibodies to heparin/PF۴ complex or receptor-binding domain (RBD) protein-PF۴ complex. Another mechanism could be the binding of anti-RBD antibodies to the RBD protein-PF۴ complex. Finally, anti-RBD or anti-PF۴ antibodies may bind to the heparin-RBD protein-PF۴ complex. The binding of either of the mentioned antibodies to these complexes via the Fc/angiotensin-converting enzyme ۲ receptors can cause activation/removal of platelets leading to thrombocytopenia and thrombosis.
Conclusion: The suggested mechanisms in this article provide a relationship between the results of anti-PF۴ antibody assays, previous exposure to heparin, and the involved mechanisms of post-vaccination thrombocytopenia and thrombotic events, which might help the experts in selecting the therapeutic measures.
Keywords:
Authors
Negar Mottaghi Dastgerdi
Department of Pharmaceutics, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran (Email: Faghihi.h@iums.ac.ir; Homafaghihipharm@gmail.com; ORCID: ۰۰۰۰-۰۰۰۳-۱۵۰۵-۴۹۳۶)
Homa Faghihi
Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran (Email: Mottaghi.n@iums.ac.ir, Mottaghi.negar@gmail.com; ORCID: ۰۰۰۰-۰۰۰۱-۸۳۸۶-۷۷۴X)
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :